arrow_back Trending Legislation
Share share

Mandatory Allergen Labeling for Human Drugs

This new act requires labels on human-use drugs to clearly state if they contain major food allergens or ingredients derived from gluten-containing grains. This will allow individuals with allergies or gluten intolerance to make safer medication choices, avoiding adverse reactions. These changes are set to take effect no later than two years after the act's enactment.
Key points
Human-use drugs must label major food allergens present in their ingredients.
Drug labels must indicate if they contain ingredients derived from gluten-containing grains (e.g., wheat, barley, rye).
The act aims to enhance consumer safety by providing better information about drug composition.
The provisions will become effective no later than two years from the act's enactment date.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
ADINA Act
Print number: HR 4263
Sponsor: Rep. Phillips, Dean [D-MN-3]
Process start date: 2023-06-21